1 row is stored for this page
| Field | Field type | Value |
|---|
| generic | String | Tretinoin (all-trans retinoic acid, ATRA) |
| brand | String | Retin-A, Renova, Atralin, Avita, Tretin-X, Refissa, Altreno; Vesanoid (oral, APL) |
| structure | File | |
| classes | List of String, delimiter: , | [[:Category:Retinoids|Retinoid]] • [[:Category:Topical_retinoids|Topical retinoid]] • [[:Category:Antineoplastics|Antineoplastic (oral • APL)]] |
| mechanism | String | |
| uses | String | '"`UNIQ--vote-00000BA0-QINU`"', '"`UNIQ--vote-00000BA1-QINU`"', '"`UNIQ--vote-00000BA2-QINU`"' |
| starting_dose | String | Topical: pea-sized amount to dry face at bedtime, building from 2-3×/week to nightly as tolerated; oral APL: 45 mg/m²/d in divided doses |
| preparations | String | Topical 0.01-0.1% creams, gels, micropsheres, lotions; oral 10 mg capsules (Vesanoid) |
| fda_max | String | Topical: nightly; oral APL: 45 mg/m²/d |
| pill_id | Text | |
| routes | List of String, delimiter: , | Topical • oral (APL only) |
| onset | String | Topical: irritation within days; acne improvement 6-12 weeks; oral APL response within days |
| duration | String | N/A |
| halflife | String | ~0.5-2 hours (oral)'"`UNIQ--ref-00000BA3-QINU`"' |
| bioavailability | String | Topical: minimal systemic absorption with normal skin; oral: variable, induced metabolism with repeated dosing'"`UNIQ--ref-00000BA4-QINU`"' |
| pregnancy | String | |
| legal | String | [[USLegal:Prescription only|Rx-only]] in US |
